Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis

Chest

Volumn 125, Issue 3, 2004, Pages 974-980

  Shin, Sonya ^a,c   Furin, Jennifer ^d   Alcántara, Félix ^d   Hyson, Anne ^d   Joseph, Keith ^a   Sánchez, Epifanio ^b   Rich, Michael ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MINISTERIO DE SALUD   (Peru)

^c Div of Social Medicine and Health Inequalities   (United States)

^d NONE

Author keywords

Capreomycin; Electrolyte; Hypokalemia; Hypomagnesemia; Magnesium; Multidrug resistant tuberculosis; Potassium; Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; KANAMYCIN; LEVOFLOXACIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTHYROIDISM; INCIDENCE; KIDNEY DYSFUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCREENING; SIDE EFFECT; STATISTICAL ANALYSIS; TUBERCULOSIS;

EID: 1642292440     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.3.974     Document Type: Article

References (21)

1. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Geneva, Switzerland: World Health Organization, 2000
2. Farmer PE, Furin JJ, Shin SS. Managing multidrug-resistant tuberculosis. J Respir Dis 2000; 21:53-56
3. Mitnick CD, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348:119-128
4. Aquinas M, Citron K. Rifampicin, ethambutol and capreomycin in pulmonary tuberculosis, previously treated with both first and second line drugs: the results of two years chemotherapy. Tubercle 1972; 53:153-165
5. Shah GH, Kirschenbaum MA. Renal magnesium wasting associated with therapeutic agents. Miner Electrolyte Metab 1991; 17:245-249
6. Elisaf M, Liberopoulos E, Bairaktari E, et al. Hypokalaemia in alcoholic patients. Drug Alcohol Rev 2002; 21:73-76
7. Elliott C, Newman N, Madan A. Gentamicin effects on urinary electrolyte excretion in healthy subjects. Clin Pharmacol Ther 2000; 67:16-21
8. Bar RS, Wilson HE, Mazzaferri EL. Hypomagnesemic hypocalcemia secondary to renal magnesium wasting. Ann Intern Med 1975; 82:646-649
9. Vanasin B, Colmer M, Davis P. Hypocalcemia, hypomagnesemia and hypokalemia during chemotherapy of pulmonary tuberculosis. Chest 1972; 61:496-499
10. Darr M, Hamburger S, Ellerbeck E. Acid-base and electrolyte abnormalities due to capreomycin. South Med J 1982; 75:627-628
11. Holmes A, Hesling C, Wilson T. Capreomycin-induced electrolyte abnormalities. Thorax 1970; 25:608-611
12. Holmes A, Hesling C, Wilson T. Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis. Q J Med 1970; 154:299-315
13. Keating M, Sethi M, Bodey G, et al. Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer 1977; 39:1410-1414
14. Steiner R, Omachi A. A Bartter's-like syndrome from capreomycin, and a similar gentamicin tubulopathy. Am J Kidney Dis 1986; 7:245-249
15. Hesling C. Treatment with capreomycin, with special reference to toxic effects. Tubercle 1996; 50:39-41
16. Beers MH, Berkow R, ed. Merck manual of diagnosis and therapy, Internet ed. 17th ed. Whitehouse Station, NJ: Merck, 1999; Ch 12, Sec 2
17. Farmer P, Walton D, Becerra M. International tuberculosis control in the 21st century. In: Friedman L, ed. Tuberculosis: current concepts and treatment. 2nd ed. Boca Raton, FL: CRC Press, 2000: 475-496
18. Partners In Health, Harvard Medical School, Bill and Melinda Gates Foundation. A DOTS-plus handbook: guide to the community-based treatment of MDR-TB. Boston, MA: Partners In Health, 2002
19. Pasechnikov A, Goncharova E, Kostornoi O, et al. Continuous use of capreomycin in multi-drug resistance tuberculosis management [abstract]. Int J Tuberc Lung Dis 2001; 5:S232
20. Schimatschek H, Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 2001; 14:283-290
21. Fukui S, Otani N, Katoh H, et al. Female gender as a risk factor for hypokalemia and QT prolongation after subarachnoid hemorrhage. Neurology 2002; 59:134-136